Skip to content

Nuvation Bio NUVB Price / book

Price / book at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
6.2×-1.0×
Pfizer logo
PfizerPFE
1.8×+0.2×
Nuvalent, Inc. logo
Nuvalent, Inc.NUVL
6.9×+1.8×
Immunome logo
ImmunomeIMNM
4.2×+2.3×
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
3.1×0.0×
Arcus Biosciences logo
Arcus BiosciencesRCUS
5.2×+3.6×

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Gross profit$9.8M+1,340%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.1B+150%
Enterprise value$2.03B+154%
P/S14.7×-62.0×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-105%-52.0pp
Net margin-102.1%-50.6pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Calculated from Nuvation Bio’s reported figures.

Based on the most recent quarter.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's price / book?
Nuvation Bio (NUVB) reported price / book of 4.7× in Q1 2026.
How has Nuvation Bio's price / book changed year-over-year?
Nuvation Bio's price / book increased by 228.4% year-over-year, from 1.4× to 4.7×.
What is the long-term trend for Nuvation Bio's price / book?
Over 5 years (2020 to 2025), Nuvation Bio's price / book has grown at a 1.7% compound annual growth rate (CAGR), from 9.2× to 10×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.